evidence: The move comes after concerns were raised earlier this year that RSV vaccination may be linked to a heightened risk of a rare nervous system condition called Guillain-Barré syndrome (GBS). The CDC advisory committee that updated the recommendations has called for more research on the topic, including a full safety analysis incorporating data from this past first full RSV season. RSV vaccination is now recommended for all people ages 75 and older. People ages 60 to 74 who are at increased risk for severe disease due to RSV should also get vaccinated. [...] "These updated recommendations are intended to maximize RSV vaccination coverage among persons most likely to benefit, by clarifying who is at highest risk and by reducing implementation barriers," the CDC report stated, particularly noting that one challenge had been last year’s advice that RSV vaccines should be given after people had a shared decision-making conversation with their medical provider. The report stated that "shared clinical decision-making has drawbacks. Providers find it confusing and time-consuming to implement."